SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood investors are bracing for heightened volatility as the company approaches its earnings announcement, with community sentiment deeply divided between those betting on a major breakout driven by prediction market growth and new revenue streams, and others anticipating a sharp sell-off due to cooling crypto activity and wider market headwinds. Traders are actively debating whether current price action represents a tactical shakeout before a move to new highs or a bearish setup, focusing heavily on the upcoming guidance and management's strategy for long-term platform expansion.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trading with heightened volatility as investors weigh strong underlying revenue growth and record member additions against a bearish flow of put activity ahead of earnings. Community discourse remains deeply divided between long-term bulls highlighting the company's ecosystem expansion and bears focusing on historical sell-offs, dilution concerns, and macro-driven price suppression.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is surging as investors cheer a massive contract expansion with Oracle to power its rapidly growing AI data center infrastructure, effectively positioning the company as a critical solution to the sector's power bottlenecks. Community sentiment remains aggressively bullish, with traders buzzing about the stock's parabolic momentum and its emerging role as essential infrastructure for the AI revolution.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending due to the announcement of a definitive agreement to acquire European Lithium in a deal valued at approximately 835 million dollars, which aims to consolidate full ownership of the Tanbreez rare earth project and simplify the company's capital structure. Community sentiment is largely bullish, with investors actively discussing the potential for a massive short squeeze due to high borrowing fees, while also monitoring for upcoming project updates and potential government support.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is generating significant debate among traders as they navigate technical resistance levels ahead of upcoming earnings, with the community closely tracking the stock's role in the evolving energy independence narrative. Discussions remain split between those anticipating a volatile post-earnings breakout driven by data center demand and VPP innovation, and those maintaining caution due to persistent macro-economic headwinds and sector-wide sentiment swings.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Seagate Technology is trending following a significant quarterly earnings beat that highlighted strong data center demand and accelerated AI-driven storage growth. Investors are actively debating the sustainability of this parabolic move, with community sentiment split between celebrating the continued 'memory supercycle' and concerns regarding valuation extremes and potential profit-taking.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks is trending ahead of its quarterly earnings release as investors scrutinize whether CEO Brian Niccol's "Back to Starbucks" turnaround plan is successfully driving traffic and margin recovery. The community remains divided, with some traders debating potential short-term volatility while others closely watch for signs of operational improvement amidst broader consumer spending headwinds.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa is trending following an earnings report that showcased robust revenue and EPS growth, with the community actively debating whether current price action represents a buying opportunity or a reaction to broader regulatory uncertainties. Investors remain focused on the company's resilient transaction volumes and global payment network dominance, even as broader market discussions weigh the potential impact of fintech disruption and shifts in consumer spending.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is currently trending following successful point-to-point test flights in New York City and ongoing FAA certification progress, fueling intense community debate regarding its long-term commercial viability. While bulls point to strong institutional backing and technical milestones, bears are focused on volatility, cash burn concerns, and competitive pressure in the crowded air taxi sector.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing high engagement following full FCC commercial approval for its 248-satellite constellation, a major regulatory milestone that investors view as a key de-risking event. Despite this, the stock faces downward pressure from institutional share liquidations and community debate regarding launch cadences, with traders actively monitoring support levels as they weigh long-term partnership potential against short-term volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Best Pharmaceutical Stocks To Keep An Eye On - April 28th

Eli Lilly and Company, Pfizer, BridgeBio Pharma, AbbVie, Novo Nordisk A/S, Abbott Laboratories, and Ascendis Pharma A/S are the seven Pharmaceutical stocks to watch today, according to MarketBeat's...

<ul class="summary-bullets"><li>Pfizer said on Tuesday that it has reached settlement agreements with three generic manufacturers — Dexcel Pharma, Hikma Pharmaceuticals and Cipla Ltd. — resolving patent-infringement lawsuits over Vyndamax.&nbsp;</li><li>The deals, filed in U.S. District Court in Delaware, effectively push the U.S. patent exclusivity for Vyndamax to June 1, 2031.</li><li>Morgan Stanley said in a note that the Pfizer settlement is at the lower end of investors' expectations.</li></ul>Shares of BridgeBio (BBIO) fell 6% on Tuesday after rival Pfizer (PFE) reached a settlement with three generic drugmakers regarding its drug Vyndamax, which Wall Street deems at the lower end of expectations.BridgeBio is a primary competitor to Pfizer in the Transthyretin Amyloid Cardiomyopathy (ATTR-CM) market, following the FDA approval of BridgeBio's drug, Attruby, which challenges Vyndamax.PFE shares traded marginally in the red at the time of writing.<h2 class="st-heading-2">Pfizer’s Settlement</h2>Pfizer Inc. (PFE) said on Tuesday that it has reached settlement agreements with three generic manufacturers — Dexcel Pharma, Hikma Pharmaceuticals and Cipla Ltd. — resolving patent-infringement lawsuits over Vyndamax.The deals, filed in U.S. District Court in Delaware, effectively push the U.S. patent exclusivity for Vyndamax to June 1, 2031, subject to the outcome of any remaining litigation. The agreements avert an earlier generic entry that Pfizer had anticipated would trigger a sharp drop in U.S. sales beginning in 2029.As a result, the company now expects Vyndamax revenues to remain relatively stable from 2028 through the middle of 2031.Vyndamax treats cardiomyopathy caused by transthyretin-mediated amyloidosis (ATTR-CM), a rare and often fatal heart condition. It holds about 75% of prescription volume in the ATTR-CM category.<h2 class="st-heading-2">Wall Street Weighs In</h2>Morgan Stanley said in a note that the Pfizer settlement is at the lower end of investors' expectations. The firm has an ‘Equal Weight’ rating and $28 price target on Pfizer shares.Mizuho and Barclays believe a "major overhang" has been removed on BBIO shares. However, Mizuho expected the terms to be favorable for Pfizer. The settlement is likely occurring somewhere in the 2033-2035 timeframe, implying BridgeBio could potentially trade into the $90-$110 range on the near-term, the analyst told investors in a research note prior to the deal details announcement.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around BBIO stock jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume increased from ‘high’ to ‘extremely high’ levels.Meanwhile, sentiment around PFE stayed within the ‘neutral’ territory while message volume remained at ‘high’ levels.A Stocktwits user highlighted that Pfizer still won the settlement deal. &nbsp;<stembedurl>https://www.stocktwits.com/Typecheck/message/651624210</stembedurl>Another said they added more BBIO shares in light of the dip.<stembedurl>https://www.stocktwits.com/sampeper/message/651638176</stembedurl>A third user termed BBIO a “screaming buy.”<stembedurl>https://www.stocktwits.com/MikeyNJ/message/651636900</stembedurl>While <a href="https://stocktwits.com/symbol/BBIO">BBIO stock</a> has gained 96% over the past 12 months, <a href="https://stocktwits.com/symbol/PFE">PFE</a> rose 15%. &nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/sngx-stock-52week-low-lymphoma-trial-fail/cZBobpeRedl">SNGX Stock Slumps To Record Low After Lymphoma Trial Fails – All Eyes Now On Behçet’s Disease Treatment</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the BridgeBio logo is displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

BBIO On Track For Worst Day In 2.5 Months: What’s The Pfizer Connection?

BridgeBio is a primary competitor to Pfizer in the Transthyretin Amyloid Cardiomyopathy (ATTR-CM) market.

Equity

BridgeBio is a primary competitor to Pfizer in the Transthyretin Amyloid Cardiomyopathy (ATTR-CM) market.


BridgeBio Pharma (NASDAQ:BBIO) Shares Gap Up - Here's What Happened

BridgeBio Pharma (NASDAQ:BBIO) Shares Gap Up - What's Next...

BridgeBio Pharma (NASDAQ:BBIO) Earns "Outperform" Rating from Mizuho

Mizuho restated an "outperform" rating and set a $106.00 price target on shares of BridgeBio Pharma in a report on Tuesday...

BridgeBio Pharma (BBIO) Expected to Announce Earnings on Tuesday

BridgeBio Pharma (NASDAQ:BBIO) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-5-bridgebio-pharma-inc-stock...

Will BridgeBio Pharma (BBIO) Report Negative Q1 Earnings? What You Should Know

BridgeBio Pharma (BBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HC Wainwright Reiterates Buy Rating for BridgeBio Pharma (NASDAQ:BBIO)

HC Wainwright reissued a "buy" rating and set a $100.00 price objective on shares of BridgeBio Pharma in a research report on Monday...

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) have been given an average recommendation of "Moderate Buy" by the twenty-five ratings firms that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating and twenty-four h...

M&T Bank Corp Takes Position in BridgeBio Pharma, Inc. $BBIO

M&T Bank Corp purchased a new stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased...

BridgeBio Pharma (NASDAQ:BBIO) CEO Sells $2,984,800.00 in Stock

BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CEO Neil Kumar sold 40,000 shares of the business's stock in a transaction that occurred on Thursday, April 9th. The stock was sold at an average price of $74.62, for a total transaction of $2,984,800.00. Following the completion of the...

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

BBIO
BridgeBio Pharma Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BBIO News

BBIOBridgeBio Pharma Inc